Ultralife Corporation (ULBI) P/E Ratio History
Deep ValueTrading at -18.5x · 0th percentile of 5-year range · Significant discount to historical valuation · Data 1996–2025
Loading P/E history...
P/E Ratio Analysis
As of June 22, 2026, Ultralife Corporation (ULBI) trades at a price-to-earnings ratio of -18.5x, with a stock price of $6.46 and trailing twelve-month earnings per share of $-0.49.
The current P/E is 175% below its 5-year average of 24.5x. Over the past five years, ULBI's P/E has ranged from a low of 5.4x to a high of 67.5x, placing the current valuation at the 0th percentile of its historical range.
Compared to the Industrials sector median P/E of 25.6x, ULBI trades at a 172% discount to its sector peers. The sector includes 403 companies with P/E ratios ranging from 0.1x to 198.8x.
Relative to the broader market, ULBI trades at a notable discount to the S&P 500 median P/E of 24.4x. Investors should consider the company's growth prospects, competitive position, and earnings quality when evaluating whether the current valuation is justified.
For a comprehensive intrinsic value estimate using discounted cash flow analysis, see our ULBI DCF Valuation Calculator →
Note: P/E ratio is just one valuation metric. It does not account for balance sheet strength, cash flow quality, or growth sustainability. Always conduct comprehensive due diligence before making investment decisions.
ULBI Cross-Benchmark Valuation
How does the current P/E compare to sector peers and the broader market?
ULBI P/E vs Peers
Battery Packs and Energy Storage Systems peers sorted by market cap
| Company | Market Cap | P/E Ratio | PEG Ratio | EPS Growth (1Y) |
|---|---|---|---|---|
| $118M | 21.9 | - | +339% | |
| $1B | 6.5Lowest | 0.17Best | +538%Best | |
| $12B | 44.7 | 3.56 | +29% | |
| $10B | 417.0 | - | +18% | |
| $22B | 60.3 | 43.40 | +5% |
Lower P/E can signal a discount or weaker growth expectations; PEG adds growth context.
ULBI Historical P/E Data (1996–2025)
Quarterly P/E ratios calculated from closing price and TTM EPS
| Quarter | Period End | Price | TTM EPS | P/E Ratio | vs Avg |
|---|---|---|---|---|---|
| FY2025 Q3 | - | $6.82 | $0.10 | 67.5x | +82% |
| FY2025 Q2 | Jun 30 2025 | $8.98 | $0.19 | 47.3x | +28% |
| FY2025 Q1 | Mar 31 2025 | $5.38 | $0.32 | 17.0x | -54% |
| FY2024 Q4 | - | $7.45 | $0.39 | 19.3x | -48% |
| FY2024 Q3 | Sep 30 2024 | $9.04 | $0.55 | 16.6x | -55% |
| FY2024 Q2 | Jun 30 2024 | $10.62 | $0.61 | 17.4x | -53% |
| FY2024 Q1 | Mar 31 2024 | $8.81 | $0.64 | 13.7x | -63% |
| FY2023 Q4 | Dec 31 2023 | $6.82 | $0.44 | 15.5x | -58% |
| FY2023 Q3 | Sep 30 2023 | $9.76 | $0.26 | 38.0x | +3% |
| FY2023 Q2 | Jun 30 2023 | $4.84 | $0.16 | 30.2x | -18% |
| FY2021 Q3 | - | $7.12 | $0.18 | 38.8x | +5% |
| FY2021 Q2 | Jun 30 2021 | $8.38 | $0.25 | 33.5x | -9% |
| FY2021 Q1 | Mar 31 2021 | $8.28 | $0.30 | 27.6x | -25% |
| FY2020 Q4 | - | $6.47 | $0.33 | 19.6x | -47% |
| FY2020 Q3 | Sep 30 2020 | $5.90 | $0.30 | 19.7x | -47% |
| FY2020 Q2 | - | $7.01 | $0.33 | 21.2x | -43% |
| FY2020 Q1 | - | $5.20 | $0.37 | 14.1x | -62% |
| FY2019 Q4 | - | $7.39 | $0.33 | 22.4x | -39% |
| FY2019 Q3 | Sep 29 2019 | $8.57 | $1.44 | 6.0x | -84% |
| FY2019 Q2 | Jun 30 2019 | $7.95 | $1.47 | 5.4x | -85% |
| FY2019 Q1 | Mar 31 2019 | $10.27 | $1.43 | 7.2x | -81% |
| FY2018 Q4 | Dec 31 2018 | $6.75 | $1.53 | 4.4x | -88% |
| FY2018 Q3 | Sep 30 2018 | $8.15 | $0.56 | 14.6x | -61% |
| FY2018 Q2 | Jul 01 2018 | $9.60 | $0.54 | 17.8x | -52% |
| FY2018 Q1 | Apr 01 2018 | $10.00 | $0.51 | 19.6x | -47% |
| FY2017 Q4 | Dec 31 2017 | $6.55 | $0.49 | 13.4x | -64% |
| FY2017 Q3 | Oct 01 2017 | $6.75 | $0.36 | 18.8x | -49% |
| FY2017 Q2 | Jul 02 2017 | $7.20 | $0.36 | 20.0x | -46% |
| FY2017 Q1 | Apr 02 2017 | $5.45 | $0.32 | 17.0x | -54% |
| FY2016 Q4 | Dec 31 2016 | $4.95 | $0.23 | 21.5x | -42% |
| FY2016 Q3 | Sep 25 2016 | $4.11 | $0.15 | 27.4x | -26% |
| FY2016 Q2 | Jun 26 2016 | $4.86 | $0.15 | 32.4x | -12% |
| FY2016 Q1 | Mar 27 2016 | $5.04 | $0.17 | 29.6x | -20% |
| FY2015 Q4 | - | $6.46 | $0.18 | 35.9x | -3% |
| FY2015 Q3 | Sep 27 2015 | $5.45 | $0.20 | 27.3x | -26% |
| FY2015 Q2 | Jun 28 2015 | $4.17 | $0.11 | 37.4x | +1% |
| FY2013 Q3 | Sep 29 2013 | $3.98 | $0.02 | 199.0x | +438% |
| FY2013 Q2 | Jun 30 2013 | $3.56 | $0.08 | 44.5x | +20% |
| FY2013 Q1 | Mar 31 2013 | $4.46 | $0.02 | 223.3x | +504% |
| FY2012 Q1 | Apr 01 2012 | $5.18 | $0.12 | 41.9x | +13% |
| FY2010 Q3 | Sep 26 2010 | $4.35 | $0.33 | 13.2x | -64% |
| FY2010 Q2 | Jun 27 2010 | $4.62 | $0.03 | 134.3x | +263% |
| FY2009 Q1 | Mar 29 2009 | $7.13 | $0.49 | 14.6x | -61% |
| FY2008 Q4 | Dec 31 2008 | $13.41 | $0.78 | 17.2x | -54% |
| FY2008 Q3 | Sep 27 2008 | $9.65 | $1.88 | 5.1x | -86% |
| FY2008 Q2 | Jun 28 2008 | $11.34 | $1.60 | 7.1x | -81% |
| FY2008 Q1 | Mar 29 2008 | $11.66 | $1.32 | 8.8x | -76% |
| FY2007 Q4 | Dec 31 2007 | $20.15 | $1.18 | 17.1x | -54% |
| FY2005 Q3 | Oct 01 2005 | $12.92 | $0.96 | 13.5x | -64% |
| FY2005 Q2 | Jul 02 2005 | $16.28 | $1.14 | 14.3x | -61% |
| FY2005 Q1 | Apr 02 2005 | $17.13 | $1.21 | 14.1x | -62% |
| FY2004 Q4 | Dec 31 2004 | $19.45 | $1.54 | 12.6x | -66% |
| FY2004 Q3 | Sep 25 2004 | $14.05 | $0.43 | 32.4x | -12% |
| FY2004 Q2 | Jun 26 2004 | $19.46 | $0.46 | 42.0x | +13% |
| FY2004 Q1 | Mar 27 2004 | $19.76 | $0.65 | 30.4x | -18% |
| FY2003 Q4 | Dec 31 2003 | $12.38 | $0.45 | 27.5x | -26% |
| FY2003 Q3 | Sep 27 2003 | $13.67 | $0.09 | 151.9x | +311% |
| FY1996 Q1 | Mar 31 1996 | $14.75 | $0.06 | 245.8x | +565% |
Average P/E for displayed period: 37.0x
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
30+ years return with dividends reinvested.
DCA Calculator
See how regular investing compounds over time.
Peer Comparison
Compare growth, multiples, and margins vs sector.
ULBI — Frequently Asked Questions
Quick answers to the most common questions about buying ULBI stock.
What is ULBI's P/E ratio?
Ultralife Corporation (ULBI) trailing twelve-month P/E ratio is -18.5x, based on TTM diluted EPS of $-0.49. The 5-year average P/E is 24.5x and the historical range spans 5.4x to 67.5x.
Is ULBI stock overvalued or undervalued?
ULBI trades at -18.5x P/E, below its 5-year average of 24.5x. At the 0th percentile of its historical range (5.4x–67.5x), the stock is priced at a discount to its own history.
Is ULBI stock expensive?
No, ULBI is not expensive on a historical basis. The current P/E of -18.5x is below the 5-year average of 24.5x and sits at the 0th percentile of its valuation range.
What is ULBI's historical P/E range?
Over the past 5 years, ULBI's P/E ratio has ranged from 5.4x to 67.5x, with a median of 19.7x and an average of 24.5x. The current P/E of -18.5x places the stock at the 0th percentile of this range. Full historical data spans 1996–2025.
How does ULBI's P/E compare to the S&P 500?
ULBI trades at -18.5x P/E versus the S&P 500 median of 24.4x. The 176% discount to the market suggests lower growth expectations or perceived higher risk.
How does ULBI's valuation compare to Industrials peers?
Ultralife Corporation P/E of -18.5x compares to the Industrials sector median of 25.6x. The discount suggests lower growth expectations, weaker margins, or higher perceived risk relative to peers. See the peer comparison table on this page for ticker-by-ticker P/E and PEG.
What is ULBI's PEG ratio?
ULBI PEG ratio is N/A, based on a P/E of -18.5x and EPS growth of -192.1%. PEG normalises P/E by growth and helps compare stocks with different earnings trajectories.
What is ULBI's earnings yield?
ULBI earnings yield is N/A, the inverse of its -18.5x P/E ratio. Earnings yield represents the percentage of each dollar invested that the company earns. It can be compared directly to bond yields to assess relative attractiveness of stocks versus fixed income.